Bionano Genomics (BNGO) Tax Provisions (2017 - 2026)

Bionano Genomics has disclosed Tax Provisions across 10 years of filings, most recently posting $10000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $10000.0, up 42.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $69000.0 (up 18.97% YoY), and the FY2025 annual result was $67000.0, up 103.03% from the prior year.
• Tax Provisions came in at $10000.0 for Q1 2026 at Bionano Genomics, down from $35000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $1.8 million in Q4 2022 to a low of -$36000.0 in Q4 2023.
• The 5-year median for Tax Provisions is $24000.0 (2024), against an average of $120823.5.
• Across the five-year window, Tax Provisions sank 169.23% in 2024 and soared 3400.0% in 2025, its largest moves.
• Bionano Genomics' Tax Provisions stood at $1.8 million in 2022, then tumbled by 101.99% to -$36000.0 in 2023, then surged by 102.78% to $1000.0 in 2024, then jumped by 3400.0% to $35000.0 in 2025, then sank by 71.43% to $10000.0 in 2026.
• The last three Tax Provisions figures came in at $10000.0 (Q1 2026), $35000.0 (Q4 2025), and $14000.0 (Q3 2025), per Business Quant data.